Targeted Repair of Heart Injury by Stem Cells Fused with Platelet Nanovesicles
Junnan Tang,Teng Su,Ke Huang,Phuong-Uyen Dinh,Zegen Wang,Adam Vandergriff,Michael T. Hensley,Jhon Cores,Tyler Allen,Taosheng Li,Erin Sproul,Emily Mihalko,Leonard J. Lobo,Laura Ruterbories,Alex Lynch,Ashley Brown,Thomas G. Caranasos,Deliang Shen,George A. Stouffer,Zhen Gu,Jinying Zhang,Ke Cheng
DOI: https://doi.org/10.1038/s41551-017-0182-x
IF: 28.1
2018-01-01
Nature Biomedical Engineering
Abstract:Stem cell transplantation, as used clinically, suffers from low retention and engraftment of the transplanted cells. Inspired by the ability of platelets to recruit stem cells to sites of injury on blood vessels, we hypothesized that platelets might enhance the vascular delivery of cardiac stem cells (CSCs) to sites of myocardial infarction injury. Here, we show that CSCs with platelet nanovesicles fused onto their surface membranes express platelet surface markers that are associated with platelet adhesion to injury sites. We also find that the modified CSCs selectively bind collagen-coated surfaces and endothelium-denuded rat aortas, and that in rat and porcine models of acute myocardial infarction the modified CSCs increase retention in the heart and reduce infarct size. Platelet-nanovesicle-fused CSCs thus possess the natural targeting and repairing ability of their parental cell types. This stem cell manipulation approach is fast, straightforward and safe, does not require genetic alteration of the cells, and should be generalizable to multiple cell types.